NCT02436707 2026-03-27Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell LymphomaCanadian Cancer Trials GroupPhase 2 Active not recruiting129 enrolled
NCT05028348 2025-12-04A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple MyelomaEuropean Myeloma Network B.V.Phase 3 Active not recruiting117 enrolled